ClinicalTrials.Veeva

Menu

Evaluation of Cardiac Burden in Patients With Sever Bronchial Asthma

A

Assiut University

Status

Not yet enrolling

Conditions

Evaluation of Cardiac Burden in Patients With Sever Bronchial Asthma

Treatments

Other: ECHO in sever asthma patient

Study type

Observational

Funder types

Other

Identifiers

NCT06223581
Cardiac burden in sever asthma

Details and patient eligibility

About

Evaluation of cardiac burden in patients with sever bronchial asthma

Full description

Bronchial asthma is chronic bronchial inflammation of variable intensity accompanied by recurrent reversible airflow obstruction and symptoms such as coughing, wheezing, shortness of breath, and chest tightness ,with a worldwide increase over the last several decades (1).

Sever asthma :means that asthma is uncontrolled despite adherence with maximal optimized therapy and treatment contributory factors or that worsens when high dose treatment is reduced. Globally. over 260 million people had poorly controlled asthma highest rate on Australia.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients accepted to be involved in the study.
  • Patients >18 years old .

Exclusion criteria

  • severe bronchial asthma patients who have other comorbidities as (chronic chest disease as COPD,ILD, bronchiectasis , , diabetic ,hypertensive ,mechanical ventilated patients, tracheostomized patients, ......)
  • patients <18 years old . patients refuse to be involved in the study .

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems